214 related articles for article (PubMed ID: 33887066)
1. Toad venom: A comprehensive review of chemical constituents, anticancer activities, and mechanisms.
Li FJ; Hu JH; Ren X; Zhou CM; Liu Q; Zhang YQ
Arch Pharm (Weinheim); 2021 Jul; 354(7):e2100060. PubMed ID: 33887066
[TBL] [Abstract][Full Text] [Related]
2. Chemical profiling and cytotoxicity assay of bufadienolides in toad venom and toad skin.
Meng Q; Yau LF; Lu JG; Wu ZZ; Zhang BX; Wang JR; Jiang ZH
J Ethnopharmacol; 2016 Jul; 187():74-82. PubMed ID: 27063985
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumor effects and 3D-quantitative structure-activity relationship analysis of bufadienolides from toad venom.
Liu JS; Deng LJ; Tian HY; Ruan ZX; Cao HH; Ye WC; Zhang DM; Yu ZL
Fitoterapia; 2019 Apr; 134():362-371. PubMed ID: 30872126
[TBL] [Abstract][Full Text] [Related]
4. Identification of Antitumor Constituents in Toad Venom by Spectrum-Effect Relationship Analysis and Investigation on Its Pharmacologic Mechanism.
Wu JH; Cao YT; Pan HY; Wang LH
Molecules; 2020 Sep; 25(18):. PubMed ID: 32961837
[TBL] [Abstract][Full Text] [Related]
5. Bufadienolides from the Bufo viridis toad venom exert cytotoxic effects on cancer cells by inducing cell apoptosis and cell cycle arrest.
Dong Q; Turdu G; Dongmulati N; Maimaitijang A; Aisa HA; Yili A
Toxicol In Vitro; 2023 Jun; 89():105566. PubMed ID: 36738868
[TBL] [Abstract][Full Text] [Related]
6. Toad venom bufadienolides and bufotoxins: An updated review.
Asrorov AM; Kayumov M; Mukhamedov N; Yashinov A; Mirakhmetova Z; Huang Y; Yili A; Aisa HA; Tashmukhamedov M; Salikhov S; Mirzaakhmedov S
Drug Dev Res; 2023 Aug; 84(5):815-838. PubMed ID: 37154099
[TBL] [Abstract][Full Text] [Related]
7. Uncovering the Mechanisms of Active Components from Toad Venom against Hepatocellular Carcinoma Using Untargeted Metabolomics.
Liang P; Ma Y; Yang L; Mao L; Sun Q; Sun C; Liu Z; Mazhar M; Yang S; Ren W
Molecules; 2022 Nov; 27(22):. PubMed ID: 36431859
[TBL] [Abstract][Full Text] [Related]
8. The Paraguayan Rhinella toad venom: Implications in the traditional medicine and proliferation of breast cancer cells.
Schmeda-Hirschmann G; Gomez CV; Rojas de Arias A; Burgos-Edwards A; Alfonso J; Rolon M; Brusquetti F; Netto F; Urra FA; Cárdenas C
J Ethnopharmacol; 2017 Mar; 199():106-118. PubMed ID: 28131913
[TBL] [Abstract][Full Text] [Related]
9. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC
Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227
[TBL] [Abstract][Full Text] [Related]
10. Multi-component identification and target cell-based screening of potential bioactive compounds in toad venom by UPLC coupled with high-resolution LTQ-Orbitrap MS and high-sensitivity Qtrap MS.
Ren W; Han L; Luo M; Bian B; Guan M; Yang H; Han C; Li N; Li T; Li S; Zhang Y; Zhao Z; Zhao H
Anal Bioanal Chem; 2018 Jul; 410(18):4419-4435. PubMed ID: 29704033
[TBL] [Abstract][Full Text] [Related]
11. Bufadienolides from amphibians: A promising source of anticancer prototypes for radical innovation, apoptosis triggering and Na
Sousa LQ; Machado KD; Oliveira SF; Araújo LD; Monção-Filho ED; Melo-Cavalcante AA; Vieira-Júnior GM; Ferreira PM
Toxicon; 2017 Mar; 127():63-76. PubMed ID: 28069354
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative activity and new argininyl bufadienolide esters from the "cururú" toad Rhinella (Bufo) schneideri.
Schmeda-Hirschmann G; Quispe C; Theoduloz C; de Sousa PT; Parizotto C
J Ethnopharmacol; 2014 Sep; 155(2):1076-85. PubMed ID: 24945399
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor.
Qi F; Li A; Inagaki Y; Kokudo N; Tamura S; Nakata M; Tang W
Int Immunopharmacol; 2011 Mar; 11(3):342-9. PubMed ID: 21185919
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative activity and chemical composition of the venom from the Amazonian toad Rhinella marina (Anura: Bufonidae).
Schmeda-Hirschmann G; Quispe C; Arana GV; Theoduloz C; Urra FA; Cárdenas C
Toxicon; 2016 Oct; 121():119-129. PubMed ID: 27616454
[TBL] [Abstract][Full Text] [Related]
15. [Study on quality control method of toad venom based on characteristic chromatogram and QAMS].
Wang PF; Fang YG; Li ZY; Chen LM; Wang ZM; Zou ZM; Gao HM
Zhongguo Zhong Yao Za Zhi; 2018 Jul; 43(14):2863-2871. PubMed ID: 30111043
[TBL] [Abstract][Full Text] [Related]
16. [Advance on quality control of toad venom and its key influence factors].
Li ZY; Qu T; Wang PF; Chen LM; Wang ZM; Gao HM
Zhongguo Zhong Yao Za Zhi; 2017 Mar; 42(5):863-869. PubMed ID: 28994527
[TBL] [Abstract][Full Text] [Related]
17. [Content of indole alkaloids and bufadienolides contained in toad medicines].
Qu T; Gao HM; Chen LM; Wang ZM; Zhang QW; Cheng YY
Zhongguo Zhong Yao Za Zhi; 2012 Oct; 37(20):3086-91. PubMed ID: 23311159
[TBL] [Abstract][Full Text] [Related]
18. Proteasome Inhibition Contributed to the Cytotoxicity of Arenobufagin after Its Binding with Na, K-ATPase in Human Cervical Carcinoma HeLa Cells.
Yue Q; Zhen H; Huang M; Zheng X; Feng L; Jiang B; Yang M; Wu W; Liu X; Guo D
PLoS One; 2016; 11(7):e0159034. PubMed ID: 27428326
[TBL] [Abstract][Full Text] [Related]
19. Arenobufagin, isolated from toad venom, inhibited epithelial-to-mesenchymal transition and suppressed migration and invasion of lung cancer cells via targeting IKKβ/NFκB signal cascade.
Zhao J; Zhang Q; Zou G; Gao G; Yue Q
J Ethnopharmacol; 2020 Mar; 250():112492. PubMed ID: 31866511
[TBL] [Abstract][Full Text] [Related]
20. Quality evaluation of traditional Chinese drug toad venom from different origins through a simultaneous determination of bufogenins and indole alkaloids by HPLC.
Zhang P; Cui Z; Liu Y; Wang D; Liu N; Yoshikawa M
Chem Pharm Bull (Tokyo); 2005 Dec; 53(12):1582-6. PubMed ID: 16327195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
